Different roles of radical scavengers – ascorbate and urate in the cerebrospinal fluid of amyotrophic lateral sclerosis patients

References

• Strong M, Rosenfield J. Amyotrophic lateral sclerosis. A review of current concepts. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 136–143.
   PubMed Web of Science ®Google Scholar
• Manfredi G, Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 2005; 5: 77–87.
   PubMed Web of Science ®Google Scholar
• Julien JP, Beaulieu JM. Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects? J Neurol Sci 2000; 180: 7–14.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Ince PG. Glutamate excitotoxicity and amyotrophic lateral sclerosis. J Neurol 1997; 244: S3–S14.
   PubMed Web of Science ®Google Scholar
• Bolanos JP, Moro MA, Lizasoain I et al. Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: therapeutic implications. Adv Drug Deily Rev 2009; 61: 1299–1315.
   PubMed Web of Science ®Google Scholar
• Tohgi H, Abe T, Yamazaki K et al. Remarkable increase in cerebrospinal fluid 3-nytrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 1999; 46: 129–131.
   PubMed Web of Science ®Google Scholar
• Tohgi H, Abe T, Yamazaki K et al. Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Neurosci Lett 1999; 260: 204–206.
   PubMed Web of Science ®Google Scholar
• Okado-Matsumoto A, Fridovich I. Amyotrophic lateral sclerosis: a proposed mechanism. Proc Natl Acad Sci USA 2002; 99: 9010–9014.
   PubMed Web of Science ®Google Scholar
• Ferrante RJ, Browne SE, Shinobu LA et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064–2074.
   PubMed Web of Science ®Google Scholar
• Smith RG, Henry YK, Mattson MP et al. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 1998; 44: 696–699.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Strong M. (eds) Motor Neuron Disorders. New York: Butterworth Heinemann, 2003; 285–313.
   Google Scholar
• Ilieva EV, Ayala V, Jove M et al. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 2007; 130: 3111–3123.
   PubMed Web of Science ®Google Scholar
• Nakagomi S, Barsoum MJ, Bossy-Wetzel E et al. A Golgi fragmentation pathway in neurodegeneration. Neurobiol Dis 2008; 29: 221–231.
   PubMed Web of Science ®Google Scholar
• Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12: 1161–1208.
   PubMed Web of Science ®Google Scholar
• Oba H, Araki T, Ohtomo K et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993; 189: 843–846.
   PubMed Web of Science ®Google Scholar
• Cheung G, Gawal MJ, Cooper PW et al. Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995; 194: 263–270.
   PubMed Web of Science ®Google Scholar
• Bowen BC, Pattany PM, Bradley WG et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. Am J Neuroradiol 2000; 21: 647–658.
   PubMed Web of Science ®Google Scholar
• Hecht MJ, Fellner F, Fellner C et al. Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images. J Neurol Sci 2002; 199: 59–65.
   PubMed Web of Science ®Google Scholar
• Yasui M, Ota K, Garruto RM. Concentrations of zinc and iron in the brains of Guamanian patients with amyotrophic lateral sclerosis and parkinsonism-dementia. Neurotoxicology 1993; 14: 445–450.
   PubMed Web of Science ®Google Scholar
• Leveugle B, Spik G, Perl DP et al. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res 1994; 650: 20–31.
   PubMed Web of Science ®Google Scholar
• Nikolic Kokic A, Stevic Z, Stojanovic S et al. Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Redox Rep 2005; 10: 265–270.
   PubMed Web of Science ®Google Scholar
• Boll MC, Alcaraz-Zubeldia M, Montes S et al. Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NOx content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem Res 2008; 33: 1717–1723.
   PubMed Web of Science ®Google Scholar
• Liu D, Wen J, Liu J et al. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J 1999; 13: 2318–2328.
   PubMed Web of Science ®Google Scholar
• Lyrer P, Landolt H, Kabiersch A et al. Levels of low molecular weight scavengers in rat brain during focal ischemia. Brain Res 1991; 567: 317–320.
   PubMed Web of Science ®Google Scholar
• Tayag EC, Nair SN, Wahhab S et al. Cerebral uric acid increases following experimental traumatic brain injury in rat. Brain Res 1996; 733: 287–291.
   PubMed Web of Science ®Google Scholar
• Langemann H, Feurerstein T, Mendelowitsch A et al. Microdialytical monitoring of uric and ascorbic acids in the brains of patients after severe brain injury and during neurovascular surgery. J Neurol Neurosurg Psychiatry 2001; 71: 169–174.
   PubMed Web of Science ®Google Scholar
• Stover JF, Lowittzsch K, Kempski OS. Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases. Neurosci Lett 1997; 238: 25–28.
   PubMed Web of Science ®Google Scholar
• Brooks, BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124: 94–107.
   Google Scholar
• Jackson SK, Liu KJ, Liu M et al. Detection and removal of contaminating hydroxylamines from the spin trap DEPMPO, and re-evaluation of its use to indicate nitrone radical cation formation and S(N)1 reactions. Free Radic Biol Med 2002; 32: 228–232.
   PubMed Web of Science ®Google Scholar
• Mojovic M, Bacic G, Vucinic Z et al. Oxygen radicals produced by plant plasma membranes: an EPR spin-trap study. J Exp Bot 2004; 55: 2523–2531.
   PubMed Web of Science ®Google Scholar
• Meret, S, Henkin, RI. Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine, and cerebrospinal fluid. Clin Chem 1971; 17: 369–374.
   PubMed Web of Science ®Google Scholar
• Okamura M. An improved method for determination of L-ascorbic acid and L-dehydroascorbic acid in blood plasma. Clin Chim Acta 1980; 103: 259–268.
   PubMed Web of Science ®Google Scholar
• Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 2006; 1762: 1051–1067.
   PubMed Web of Science ®Google Scholar
• Buettner G, Jurkiewicz BA. Catalytic metals, ascorbate and free radicals: combination to avoid. Radiat Res 1996; 145: 532–541.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Vitamin C: poison, prophylactic or panacea? Trends Biochem Sci 1999; 24: 255–259.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 4th edn. Oxford: Oxford University Press, 2007.
   Google Scholar
• Chen Q, Espey GM, Krishna MC et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 2005; 102: 13604–13609.
   PubMed Web of Science ®Google Scholar
• Spasojevic I, Mojovic M, Stevic Z et al. Bioavailability and catalytic properties of copper and iron for Fenton chemistry in human cerebrospinal fluid. Redox Rep 2009; 15: 29–35.
   Web of Science ®Google Scholar
• Castro MA, Beltran FA, Brauchi S, Concha II. A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid. J Neurochem 2009; 110: 423–440.
   PubMed Web of Science ®Google Scholar
• Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 2009; 46: 719–730.
   PubMed Web of Science ®Google Scholar
• Hooper DC, Scott GS, Zborek A et al. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J2000; 14: 691-698.
   Google Scholar
• Whiteman M, Ketsawatsakul U, Halliwell B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann NY Acad Sci 2002; 962: 242–259.
   PubMed Web of Science ®Google Scholar
• O'Neill RD, Lowry JP. On the significance of brain extracellular uric acid detected with in-vivo monitoring techniques: a review. Behav Brain Res 1995; 71: 33–49.
   PubMed Web of Science ®Google Scholar
• Dujmovic I, Pekmezovic T, Obrenovic R et al. Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis. Clin Chem Lab Med 2009; 47: 848–853.
   PubMed Web of Science ®Google Scholar